Potential Cancer Breakthrough: Common Antidepressant Effective Against Brain Tumors

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain cancer. In a large-scale drug screening, the antidepressant, vortioxetine emerged as one of the most effective agents against these types of cancer cells. Clinical trials are already […]

Source link